Cianferoni silvia pinal biography
•
•
Content Posted in 2024
Link
030 : THE EFFECTS OF HYPOTONIC DIALYSIS AND SPIN COLUMNS ON SERUM ANTI-HLA IgG LEVELS, Michael B. Solomon, Matthew Fair, Angela Kessler, Jennifer Mendiolina, and Robert Cirocco PhD
Link
033. Opioid-Induced, Life-Threatening Sickle Cell Crises in a Pediatric Patient, Ashley Griswold DO, Erica K. Mason, Andrew L. Koons DO, Kenneth D. Katz MD, Robert D. Cannon, Gillian A. Beauchamp MD, and Matthew D. Cook DO
Link
0629 The Lehigh Valley Health Network Narcolepsy Cohort: Clinical and Polysomnographic Analysis of 303 Cases, Irene Chu MPH, MD; Rena Y Jiang; Roger Rochart; Shae Duka MPH; and Martina Vendrame MD, PhD
Link
095. Levamisole: a Classic Adulterant with a Novel Association, Will Goodrich, Paul Wax, Kim Aldy, Rachel Culbreth, Alex Krotulski, Jeffrey Brent, Sharan Campleman, Barry Logan, and Alexandra Amaducci DO
Link
1011: What is the optimal maternal Vitamin D level for the prediction of adverse maternal outcomes?, Malini D. Persad MD, C L. Staszewski, F Khan, F Chiu, T Perseleni, M Demishev, D Garry, K Herrera, and D Garretto
Link
1029: Optimization of labor and delivery procedure flow using six sigma, J L. Maines, Cori Shollenberger MD, A Brinton, J O'Brien, A Hameroff, S Ural, and J Pauli
Link
103: Foley plus oxytocin versus oxyto
•
Clinical management of the hypereosinophilicsyndromes.
PubMed
Cogan, Elie; Roufosse, Florence
2012-06-01
Hypereosinophilicsyndromes (HESs) are rare disorders characterized by marked hypereosinophilia that is directly responsible for organ damage or dysfunction. Different pathogenic mechanisms have been discovered in patient subgroups leading to the characterization of myeloproliferative and lymphocytic disease variants. In the updated terminology, idiopathic HES is now restricted to patients with HES of undetermined etiology. The practical clinical approach of patients with the different HES variants is reviewed herein, focusing on specific diagnostic tools and therapeutic options. Corticosteroids, hydroxyurea and IFN-α remain the classical agents for treatment of most patients with HESs. The specific role of therapeutic compounds that have become available more recently, namely, tyrosine kinase inhibitors and IL-5 antagonists, is discussed.
Eosinophilic Pleural Effusion: A Rare Manifestation of HypereosinophilicSyndrome
PubMed Central
Okafor, Ndubuisi C.; Oso, Ayodeji A.; Oranu, Amanke C.; Wolff, Steven M.; Murray, John J.
2009-01-01
Several causes of eosinophilic pleural effusions have been described with malignancy being the commonest cause. Hypereosinophilicsyn